Ceftron 250 mg/vial (IM Injection)
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Square pharmaceuticals plc |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
Ceftriaxone is a 3rd generation broad-spectrum parenteral cephalosporin antibiotic with bactericidal activity against a wide range of Gram-positive and Gram-negative organisms. It interferes with the synthesis of the bacterial cell wall and has a relatively long plasma elimination half-life of about 6 to 9 hours.
Dosage
- 1 to 2 gm by intravenous or intramuscular administration once a day (or in equally divided doses twice a day)
- 250 mg IM as a single dose for uncomplicated gonococcal infections
- 1 g IV as a single dose 30 to 120 minutes before surgery for surgical prophylaxis
- 50 to 75 mg/kg intravenous or intramuscular administration once a day for infants and children (01 month or older)
Administration
- Preparation of Solutions for Intramuscular/Intravenous Injections
- 250 mg or 500 mg Ceftriaxone should be dissolved in 2 ml Lidocaine HCI 1% injection for Intramuscular Injection
- 250 mg or 500 mg Ceftriaxone should be dissolved in 5 ml of Water for injection for Intravenous Injection
- Injection should be administered over 2-4 minutes for Intramuscular or Intravenous injection or by tubing infusion over a period of 30 minutes
Interaction
No drug interactions reported
Contraindications
Patients with a history of hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea, vomiting
- Cutaneous reactions including rash, pruritus, urticaria
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, headache
Pregnancy & Lactation
Not established for safety in human pregnancy; caution in lactating mothers
Precautions & Warnings
- Anaphylactic shock cannot be ruled out
- Shadows suggesting sludge have been detected by sonograms of the gallbladder
- Blood picture should be checked at regular intervals during prolonged treatment
Use in Special Populations
Ceftron must not be given to neonates if premature and newborn (up to 28 days of age)
Overdose Effects
No specific antidote; treatment should be symptomatic
Therapeutic Class
Third generation Cephalosporins
Storage Conditions
Store in a cool, dry place (below 30°C), away from light & moisture; keep out of reach of children
Related Brands
- Ceftron 500 mg/vial (IM Injection) - square-pharmaceuticals-plc
- Ceftron 250 mg/vial (IV Injection) - square-pharmaceuticals-plc
- Ceftron 500 mg/vial (IV Injection) - square-pharmaceuticals-plc
- Ceftron 1 gm/vial (IV Injection) - square-pharmaceuticals-plc
- Ceftron 2 gm/vial (IV Injection) - square-pharmaceuticals-plc